Avid Bioservices Inc (CDMO)

[realist1]

RE "sale or licensing of Cotara can provide enough money for bavi to be further developed"

Yes, that would be great, but there lies the problem. People are excited about the recent stock run, but the bottom line is nothing has changed for PPHM. The two huge problems still remain. 1. Delisting or reverse split. 2. CASH. Phase 3 takes many tens of millions, perhaps ~$100 million and PPHM doesn't have anything close to the resources to do ANY phase 3's. So will they get the cash, and if they do what are the terms? If it's PIPES and dilution, shareholders will be slaughtered. If it's a "partner", they better hurry. Time is money is a very appropriate saying here. Other problem is that Bavi needs a decent immune system to do its work and patients in these trials aren't ideal which is why results have been so-so compared to SOC and Avastin. Will Bavi need MORE phase 2's? That's another important question and problem.
Time and money...............2 things PPHM doesn't do well with. Better deal Cotara ASAP for this company to have a fighting change with Bavi. Unfortunately when it comes to bringing in CASH, this team has showed poor results.

All my opinion of course..........